TP53 and breast carcinoma: In breast cancer with mutant TP53, higher p53γ expression levels are associated with good prognosis to levels comparable with the wild-type TP53 status, while the absence of p53γ expression with the mutant TP53 status is associated with a particularly poor prognosis [149].